TY - JOUR
T1 - Survivorship, Version 1.2022 Featured Updates to the NCCN Guidelines
AU - Sanft, Tara
AU - Day, Andrew
AU - Peterson, Lindsay
AU - Rodriguez, M. Alma
AU - Ansbaugh, Shannon
AU - Armenian, Saro
AU - Baker, K. Scott
AU - Ballinger, Tarah
AU - Broderick, Gregory
AU - Demark-Wahnefried, Wendy
AU - Dickinson, Kristin
AU - Fairman, Nathan Paul
AU - Friedman, Debra L.
AU - Goldman, Mindy
AU - Henry, Norah Lynn
AU - Hill-Kayser, Christine
AU - Hudson, Melissa
AU - Khakpour, Nazanin
AU - Koura, Divya
AU - McDonough, Allison L.
AU - Melisko, Michelle
AU - Mooney, Kathi
AU - Moore, Halle C.F.
AU - Moryl, Natalie
AU - Neuman, Heather
AU - O’Connor, Tracey
AU - Overholser, Linda
AU - Paskett, Electra D.
AU - Patel, Chirayu
AU - Pirl, William
AU - Porpiglia, Andrea
AU - Ruddy, Kathryn J.
AU - Schapira, Lidia
AU - Shockney, Lillie
AU - Smith, Sophia
AU - Syrjala, Karen L.
AU - Tevaarwerk, Amye
AU - Yang, Eric H.
AU - Zee, Phyllis
AU - McMillian, Nicole R.
AU - Freedman-Cass, Deborah A.
N1 - Funding Information:
Eric H. Yang, MD, Panel Member, has disclosed receiving grant/research support from Boehringer Ingelheim GmbH, CSL Behring, and Eli Lilly and Company; and receiving consulting fees from Pfizer Inc. Phyllis Zee, MD, PhD, Panel Member, has disclosed serving as a scientific advisor for CVS Caremark, Idorsia Pharmaceuticals Ltd., Jazz Pharmaceuticals Inc., and sanofi-aventis U.S.; receiving consulting fees from CVS Caremark, Eisai Inc., Idorsia Pharmaceuticals Ltd., and Jazz Pharmaceuticals Inc.; receiving grant/research support from Vanda Pharmaceuticals Inc.; and owning equity interest/stock options in Teva Pharmaceuticals.
Funding Information:
This activity is supported by educational grants from AstraZeneca; BeiGene; Exact Sciences; Gilead Sciences, Inc.; GlaxoSmithKline; Lantheus Medical Imaging Inc.; Novartis; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Taiho Oncology, Inc. This activity is supported by an independent educational grant from Astellas. This activity is supported by an education grant from Astellas and Seagen Inc. This activity is supported by a medical education grant from Karyopharm® Therapeutics. This activity is supported through an Independent Medical Education grant from Merck & Co., Inc.
Publisher Copyright:
© JNCCN—Journal of the National Comprehensive Cancer Network.
PY - 2022/10
Y1 - 2022/10
N2 - The NCCN Guidelines for Survivorship are intended to help healthcare professionals who work with survivors to ensure that the survivors’ complex and varied needs are addressed. The NCCN Guidelines provide screening, evaluation, and treatment recommendations for the consequences of adult-onset cancer and its treatment; recommendations to help promote physical activity, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes updates to the NCCN Guidelines pertaining to preventive health for cancer survivors, including recommendations about alcohol consumption and vaccinations.
AB - The NCCN Guidelines for Survivorship are intended to help healthcare professionals who work with survivors to ensure that the survivors’ complex and varied needs are addressed. The NCCN Guidelines provide screening, evaluation, and treatment recommendations for the consequences of adult-onset cancer and its treatment; recommendations to help promote physical activity, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes updates to the NCCN Guidelines pertaining to preventive health for cancer survivors, including recommendations about alcohol consumption and vaccinations.
UR - http://www.scopus.com/inward/record.url?scp=85139885137&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2022.0052
DO - 10.6004/jnccn.2022.0052
M3 - Article
C2 - 36240847
AN - SCOPUS:85139885137
SN - 1540-1405
VL - 20
SP - 1080
EP - 1090
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 10
ER -